Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
7
CLRB Quote, Financials, Valuation and Earnings
Last price:
$5.02
Seasonality move
:
-13.76%
Day range:
$4.88 - $5.30
52-week range:
$4.36 - $94.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
137.94x
P/B ratio:
1.18x
Volume:
157.7K
Avg. volume:
908.7K
1-year change:
-93.98%
Market cap:
$9.1M
Revenue:
--
EPS (TTM):
-$21.90
Earnings Data
Next earnings date for CLRB
Aug 13
2025
Most recent earnings per share
-$4.20
Beat by $0.70
(May 13/2025)
Consensus Estimate
-$4.90
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CLRB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$3.60 | -- |
| 08/13/2025 | Q2 | -- | -- | -- | -$3.70 | -- |
| 05/13/2025 | Q1 | -- | -- | -$4.20 | -$4.90 | $0.70 |
| 03/13/2025 | Q4 | -- | -- | -$0.30 | -$10.58 | $10.28 |
| 11/18/2024 | Q3 | -- | -- | -$12.00 | -$11.20 | -$0.80 |
| 08/13/2024 | Q2 | -- | -- | -$5.40 | -$8.10 | $2.70 |
| 05/14/2024 | Q1 | -- | -- | -$27.30 | -$16.90 | -$10.40 |
| 03/27/2024 | Q4 | -- | -- | -$12.30 | -$15.90 | $3.60 |
| 11/02/2023 | Q3 | -- | -- | -$46.50 | -$13.35 | -$33.15 |
| 08/04/2023 | Q2 | -- | -- | -$27.00 | -$19.95 | -$7.05 |
| 05/10/2023 | Q1 | -- | -- | -$19.20 | -- | -- |
| 03/21/2023 | Q4 | -- | -- | -$30.30 | -- | -- |
| 11/08/2022 | Q3 | -- | -- | -$38.40 | -- | -- |
| 08/05/2022 | Q2 | -- | -- | -$36.60 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | -$30.00 | -- | -- |
| 03/02/2022 | Q4 | -- | -- | -$28.80 | -- | -- |
| 11/08/2021 | Q3 | -- | -- | -$29.10 | -- | -- |
| 08/09/2021 | Q2 | -- | -- | -$34.20 | -- | -- |
| 05/10/2021 | Q1 | -- | -- | -$39.00 | -- | -- |
| 03/02/2021 | Q4 | -- | -- | -$21.00 | -- | -- |
| 11/09/2020 | Q3 | -- | -- | -$45.00 | -- | -- |
| 08/10/2020 | Q2 | -- | -- | -$78.00 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$126.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$99.00 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$126.00 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$138.00 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$228.00 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$242.65 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$495.00 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$507.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$621.00 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$1,020.00 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$774.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$696.00 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$720.00 | -- | -- |
| 03/15/2017 | Q4 | -- | -- | -$1,668.14 | -- | -- |
| 11/11/2016 | Q3 | -- | -- | -$1,290.00 | -- | -- |
| 08/15/2016 | Q2 | -- | -- | -$1,470.00 | -- | -- |
| 05/12/2016 | Q1 | -- | -- | $2,883.09 | -- | -- |
| 03/10/2016 | Q4 | -- | -- | $3,324.87 | -- | -- |
| 11/12/2015 | Q3 | -- | -- | -$7,373.96 | -- | -- |
Cellectar Biosciences Earnings Questions
-
How Much did Cellectar Biosciences Generate in Revenue Last Quarter?
Cellectar Biosciences reported -- worth of top line sales in its most recent quarter.
-
Did Cellectar Biosciences Beat Earnings Last Quarter?
Cellectar Biosciences announced earnings per share of -$4.20 which represents a beat of analyst forecast a -$4.90 per share.
-
Is Cellectar Biosciences Profitable?
Cellectar Biosciences reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Cellectar Biosciences EPS Next Year?
Cellectar Biosciences's earnings are forecast to decrease from -$42.00 per share to -$47.03 per share next year representing a decrease of -63.33%.
-
When is Cellectar Biosciences's Earnings Date?
Cellectar Biosciences's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
